Table 2.
Study groups | P |
---|---|
Control versus PMD | 0.1332 (nonsignificant) |
Control versus OSCC | 0.000 (highly significant) |
PMD versus OSCC | 0.000 (highly significant) |
PMD: Potentially malignant disorders, OSCC: Oral squamous cell carcinoma
Study groups | P |
---|---|
Control versus PMD | 0.1332 (nonsignificant) |
Control versus OSCC | 0.000 (highly significant) |
PMD versus OSCC | 0.000 (highly significant) |
PMD: Potentially malignant disorders, OSCC: Oral squamous cell carcinoma